| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |